What is Mineralys Therapeutics, Inc. Common Stock's Market Cap?

Mineralys Therapeutics, Inc. Common Stock's Market Cap is $2.8B, based on as-reported figures from SEC (XBRL) filings.

What is Mineralys Therapeutics, Inc. Common Stock's Enterprise Value?

Mineralys Therapeutics, Inc. Common Stock's Enterprise Value is $2.6B, based on as-reported figures from SEC (XBRL) filings.

What is Mineralys Therapeutics, Inc. Common Stock's EV / EBITDA?

Mineralys Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Mineralys Therapeutics, Inc. Common Stock's Net Income (TTM)?

Mineralys Therapeutics, Inc. Common Stock's Net Income (TTM) is -$349.6M, based on as-reported figures from SEC (XBRL) filings.

What is Mineralys Therapeutics, Inc. Common Stock's EBITDA?

Mineralys Therapeutics, Inc. Common Stock's EBITDA is -$370.8M, based on as-reported figures from SEC (XBRL) filings.

What is Mineralys Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Mineralys Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.95, based on as-reported figures from SEC (XBRL) filings.

What is Mineralys Therapeutics, Inc. Common Stock's Net Debt?

Mineralys Therapeutics, Inc. Common Stock's Net Debt is -$138.2M, based on as-reported figures from SEC (XBRL) filings.

Mineralys Therapeutics, Inc. Common Stock (MLYS) Financial Statements

Mineralys Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00ZXN1GR9

XNAS · usd

31.12▲ 2.91 (10.32%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close28.21

Day's Range28.03 – 31.59

52-Week Range22.30 – 47.65

Volume2.6M

Avg Volume863.2K

Share Statistics

Shares Outstanding

Employees76

ExchangeXNAS

Listed2023-02-10

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Mineralys Therapeutics, Inc. Common Stock (MLYS)

What is Mineralys Therapeutics, Inc. Common Stock's Market Cap?: Mineralys Therapeutics, Inc. Common Stock's Market Cap is $2.8B, based on as-reported figures from SEC (XBRL) filings.
What is Mineralys Therapeutics, Inc. Common Stock's Enterprise Value?: Mineralys Therapeutics, Inc. Common Stock's Enterprise Value is $2.6B, based on as-reported figures from SEC (XBRL) filings.
What is Mineralys Therapeutics, Inc. Common Stock's EV / EBITDA?: Mineralys Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Mineralys Therapeutics, Inc. Common Stock's Net Income (TTM)?: Mineralys Therapeutics, Inc. Common Stock's Net Income (TTM) is -$349.6M, based on as-reported figures from SEC (XBRL) filings.
What is Mineralys Therapeutics, Inc. Common Stock's EBITDA?: Mineralys Therapeutics, Inc. Common Stock's EBITDA is -$370.8M, based on as-reported figures from SEC (XBRL) filings.
What is Mineralys Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Mineralys Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.95, based on as-reported figures from SEC (XBRL) filings.
What is Mineralys Therapeutics, Inc. Common Stock's Net Debt?: Mineralys Therapeutics, Inc. Common Stock's Net Debt is -$138.2M, based on as-reported figures from SEC (XBRL) filings.